Entospletinib,Lanraplenib
Kronos Bio,gilead
[]
$kron [15s. delayed]: issued press release on june 10, 03:04:00: kronos bio continues to advance investigational syk inhibitors entospletinib and lanraplenib with new preclinical data at eha2022 congress 
Flash Alert is a low-latency financial news service which sources SEC, press releases, credible news sources to get your news about stocks in near real-time